安楽力

アンラクツトム | Anraku tsutomu

所属機関・部署：
論文 (10件)：

Tsutomu Anraku, Masaki Murata, Hiroo Kuroki, Akira Kazama, Yuko Shirono, Masayuki Tasaki, Vladimir Bilim, Yoshihiko Tomita. Selective HDAC6 Inhibition Has the Potential for Anti-Cancer Effect in Renal Cell Carcinoma. Journal of personalized medicine. 2024. 14. 7
Yuko Shirono, Vladimir Bilim, Tsutomu Anraku, Hiroo Kuroki, Akira Kazama, Masaki Murata, Kaede Hiruma, Yoshihiko Tomita. Targeting Pro-Survival Autophagy Enhanced GSK-3β Inhibition-Induced Apoptosis and Retarded Proliferation in Bladder Cancer Cells. Current oncology (Toronto, Ont.). 2023. 30. 6. 5350-5365
Tsutomu Anraku, Hideki Hashidate, Asa Nakahara, Tomoyuki Imai, Yoshiaki Kawakami. Sarcomatoid urothelial carcinoma of the renal pelvis treated with immunotherapy. BMC urology. 2023. 23. 1. 38-38
Akira Kazama, Vladimir Bilim, Masayuki Tasaki, Tsutomu Anraku, Hiroo Kuroki, Yuko Shirono, Masaki Murata, Kaede Hiruma, Yoshihiko Tomita. Tumor-infiltrating immune cell status predicts successful response to immune checkpoint inhibitors in renal cell carcinoma. Scientific reports. 2022. 12. 1. 20386-20386
Tsutomu Anraku, Hideki Hashidate, Asa Nakahara, Tomoyuki Imai, Yoshiaki Kawakami. A 40-year-old man with a rapidly growing intrascrotal tumor in the fibroma-thecoma group. IJU case reports. 2022. 5. 3. 175-178

MISC (3件)：

学位 (1件)：

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

安楽 力